Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641) Merck KGaA, 17 Jun 2014 Accessed on 23 Jun 2014 from http://news.emdgroup.com/N/0/CA6B3B25E9032894C1257CFA001FE133/$File/OnoEMD.pdf. CommentRecommendBookmarkWatch